Rheumatic Diseases  >>  MK-0359  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MK-0359 / Merck (MSD)
NCT00482417: Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

Completed
2
11
US
MK0359
Merck Sharp & Dohme LLC
Rheumatoid Arthritis
05/03
05/03

Download Options